lomerizine and verapamil

lomerizine has been researched along with verapamil in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (50.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anger, T; Madge, DJ; Mulla, M; Riddall, D	1
Handa, J; Kidooka, M; Shiino, A	1
Iwamoto, T; Morita, T; Nishimura, N; Sukamoto, T	1
Hamada, A; Nakano, M; Ohmura, T; Oyama, N; Shiraki, N; Tokunaga, J	1

Reviews

2 review(s) available for lomerizine and verapamil

Article	Year
Medicinal chemistry of neuronal voltage-gated sodium channel blockers. Journal of medicinal chemistry, 2001, Jan-18, Volume: 44, Issue:2 Topics: Amyotrophic Lateral Sclerosis; Analgesics; Anticonvulsants; Epilepsy; Humans; Ion Channel Gating; Models, Molecular; Mutation; Nerve Tissue Proteins; Neuroprotective Agents; Protein Binding; Sodium Channel Blockers; Sodium Channels; Stroke	2001
[Ca antagonists in neurosurgical practice]. No to shinkei = Brain and nerve, 1990, Volume: 42, Issue:1 Topics: Animals; Anticonvulsants; Brain; Calcium Channel Blockers; Cerebral Infarction; Disease Models, Animal; Fatty Acids, Nonesterified; Flunarizine; Humans; Intracranial Aneurysm; Ischemic Attack, Transient; Nimodipine; Piperazines; Verapamil	1990

Other Studies

2 other study(ies) available for lomerizine and verapamil

Article	Year
Differential vasorelaxant effects of K(+)-channel openers and Ca(2+)-channel blockers on canine isolated arteries. The Journal of pharmacy and pharmacology, 1993, Volume: 45, Issue:4 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Arteries; Benzopyrans; Calcium Channel Blockers; Cromakalim; Dogs; Female; Guanidines; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Pinacidil; Piperazines; Potassium Channels; Prostaglandin Endoperoxides, Synthetic; Pyrroles; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents; Verapamil	1993
Increase in doxorubicin cytotoxicity by inhibition of P-glycoprotein activity with lomerizine. Biological & pharmaceutical bulletin, 2001, Volume: 24, Issue:5 Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium Channel Blockers; Doxorubicin; Drug Resistance, Multiple; Fluoresceins; Humans; K562 Cells; Piperazines; Rhodamine 123; Verapamil	2001

Article

Year

Differential vasorelaxant effects of K(+)-channel openers and Ca(2+)-channel blockers on canine isolated arteries.

The Journal of pharmacy and pharmacology, 1993, Volume: 45, Issue:4

Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Arteries; Benzopyrans; Calcium Channel Blockers; Cromakalim; Dogs; Female; Guanidines; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Pinacidil; Piperazines; Potassium Channels; Prostaglandin Endoperoxides, Synthetic; Pyrroles; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents; Verapamil

1993

Increase in doxorubicin cytotoxicity by inhibition of P-glycoprotein activity with lomerizine.

Biological & pharmaceutical bulletin, 2001, Volume: 24, Issue:5

Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium Channel Blockers; Doxorubicin; Drug Resistance, Multiple; Fluoresceins; Humans; K562 Cells; Piperazines; Rhodamine 123; Verapamil

2001